selected publications
- Unraveling the Role of PET in Cervical Cancer: Review of Current Applications and Future Horizons. Journal of imaging. 2025 Review GET IT
-
Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial.
The Lancet. Oncology.
2024
Academic Article
GET IT
Times cited: 3 - First-in-human imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostate. 2024 GET IT